Prathyusha Durabaibu
Net worth: 507 735 $ as of 30/06/2026
Net worth: 507 735 $ as of 30/06/2026
Ms. Prathyusha Durabaibu is an Independent Director at Organogenesis Holdings, Inc. She is on the Board of Directors at Organogenesis Holdings, Inc. Ms. Durabaibu was previously employed as a Principal Financial Officer by Sangamo Therapeutics, Inc. and a Controller by Pacific Biosciences of California, Inc. She received her undergraduate degree from Oxford Brookes University and an MBA from San Jose State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/04/2026 | 1,98,219 ( 0.15% ) | 481 672 $ | 30/06/2026 | |
| 22/01/2026 | 4,82,645 ( 0.12% ) | 26 063 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Director/Board Member | 19/11/2021 |
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director of Finance/CFO | 03/02/2026 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Comptroller/Controller/Auditor | 01/03/2019 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Oxford Brookes University
Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organogenesis Holdings, Inc.
Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets | Health Technology |
Select your edition
All financial news and data tailored to specific country editions